Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosis

J Mol Cell Cardiol. 2021 Jul:156:69-78. doi: 10.1016/j.yjmcc.2021.03.010. Epub 2021 Mar 26.

Abstract

One of the hallmarks of atherosclerosis is ongoing accumulation of macrophages in the artery intima beginning at disease onset. Monocyte recruitment contributes to increasing macrophage abundance at early stages of atherosclerosis. Although the chemokine CCL5 (RANTES) has been studied in atherosclerosis, its role in the recruitment of monocytes to early lesions has not been elucidated. We show that expression of Ccl5 mRNA, as well as other ligands of the CCR5 receptor (Ccl3 and Ccl4), is induced in the aortic intima of Ldlr-/- mice 3 weeks after the initiation of cholesterol-rich diet (CRD)-induced hypercholesterolemia. En face immunostaining revealed that CCL5 protein expression is also upregulated at 3 weeks of CRD. Blockade of CCR5 significantly reduced monocyte recruitment to 3-week lesions, suggesting that chemokine signaling through CCR5 is critical. However, we observed that Ccl5-deficiency had no effect on early lesion formation and CCL5-blockade did not affect monocyte recruitment in Ldlr-/- mice. Immunostaining of the lesions in Ldlr-/- mice and reciprocal bone marrow transplantation (BMT) of Ccl5+/+ and Ccl5-/- mice revealed that CCL5 is expressed by both myeloid and endothelial cells. BMT experiments were carried out to determine if CCL5 produced by distinct cells has functions that may be concealed in Ccl5-/-Ldlr-/- mice. We found that hematopoietic cell-derived CCL5 regulates monocyte recruitment and the abundance of intimal macrophages in 3-week lesions of Ldlr-/- mice but plays a minor role in 6-week lesions. Our findings suggest that there is a short window in early lesion formation during which myeloid cell-derived CCL5 has a critical role in monocyte recruitment and macrophage abundance.

Keywords: Atherosclerosis; CCL5; CCR5; Chemokines; Monocytes; Recruitment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / etiology*
  • Atherosclerosis / metabolism*
  • Atherosclerosis / pathology
  • Biomarkers*
  • Chemokine CCL5 / genetics*
  • Chemokine CCL5 / metabolism
  • Disease Models, Animal
  • Disease Progression
  • Disease Susceptibility*
  • Endothelial Cells / metabolism
  • Female
  • Fluorescent Antibody Technique
  • Gene Expression Regulation
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Knockout
  • Myeloid Cells / metabolism*
  • RNA, Messenger / genetics
  • Signal Transduction

Substances

  • Biomarkers
  • Chemokine CCL5
  • RNA, Messenger

Grants and funding